IBIO vs MTCH · rev $100.0K vs P/E 13, rev $1.72B
iBio, Inc. Common Stock (IBIO) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Latest reported MTCH revenue for 2026-06-30 was $1.72B. Net income was $337.4M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
IBIO currently screens at market cap $13.4M. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the IBIO and MTCH stock pages for the full models.
Not investment advice.